Trillium Therapeutics Inc. (TRIL) NASDAQ

$18.44 - (-)

Market Cap: -

As of 11/16/21 12:00 AM EST. Market closed.

(TRIL)

Trillium Therapeutics Inc. (TRIL)
NASDAQ

$18.44
- (-)

Market Cap: -

As of 11/16/21 12:00 AM EST. Market closed.

Add to Portfolio

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune ... read more

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
33
Address
.
PRICE CHART FOR TRILLIUM THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$18.45
Previous Close
$18.44
Days Range
$17.83 - $18.49
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
104,995,125
Open
$18.45
Previous Close
$18.44
Days Range
$17.83 - $18.49
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
104,995,125
FINANCIAL STATEMENTS FOR TRILLIUM THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TRILLIUM THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Uger RobertChief Scientific OfficerJul 07, 2021 Option Exercise$0.303,6461,1083,646Jul 09, 2021, 04:30 PM
Uger RobertChief Scientific OfficerJul 07, 2021 Sale$9.003,64632,8140Jul 09, 2021, 04:30 PM
Uger RobertChief Scientific OfficerApr 07, 2021 Option Exercise$0.303,6461,0983,646Apr 09, 2021, 05:38 PM
Uger RobertChief Scientific OfficerApr 07, 2021 Sale$10.823,64639,4500Apr 09, 2021, 05:38 PM
Petrova PenkaChief Development OfficerApr 08, 2021 Option Exercise$1.805,3129,5785,312Apr 09, 2021, 05:23 PM
Petrova PenkaChief Development OfficerApr 08, 2021 Sale$11.095,31258,9100Apr 09, 2021, 05:23 PM
Uger RobertChief Scientific OfficerMar 12, 2021 Option Exercise$3.392,9179,8962,917Mar 15, 2021, 05:12 PM
Uger RobertChief Scientific OfficerMar 12, 2021 Sale$11.972,91734,9160Mar 15, 2021, 05:12 PM
Petrova PenkaChief Development OfficerMar 10, 2021 Option Exercise$1.805,3129,5455,312Mar 12, 2021, 04:40 PM
Petrova PenkaChief Development OfficerMar 10, 2021 Sale$11.085,31258,8570Mar 12, 2021, 04:40 PM
Uger RobertChief Scientific OfficerMar 08, 2021 Option Exercise$0.303,6461,0933,646Mar 10, 2021, 05:57 PM
Uger RobertChief Scientific OfficerMar 08, 2021 Sale$10.113,64636,8610Mar 10, 2021, 05:57 PM
Petrova PenkaChief Development OfficerFeb 09, 2021 Option Exercise$9.625084,888508Feb 10, 2021, 07:18 PM
Petrova PenkaChief Development OfficerFeb 08, 2021 Option Exercise$1.785,3129,4355,312Feb 10, 2021, 07:18 PM
Petrova PenkaChief Development OfficerFeb 09, 2021 Sale$14.175087,2000Feb 10, 2021, 07:18 PM
Petrova PenkaChief Development OfficerFeb 08, 2021 Sale$12.655,31267,1970Feb 10, 2021, 07:18 PM
Uger RobertChief Scientific OfficerFeb 09, 2021 Option Exercise$9.625845,619584Feb 10, 2021, 07:18 PM
Uger RobertChief Scientific OfficerFeb 08, 2021 Option Exercise$1.646,56310,7516,563Feb 10, 2021, 07:18 PM
Uger RobertChief Scientific OfficerFeb 09, 2021 Sale$14.125848,2480Feb 10, 2021, 07:18 PM
Uger RobertChief Scientific OfficerFeb 08, 2021 Sale$12.656,56383,0220Feb 10, 2021, 07:18 PM
Skvarka JanPresident and CEOJan 13, 2021 Option Exercise$0.425,4192,3025,419Jan 15, 2021, 04:19 PM
Skvarka JanPresident and CEOJan 14, 2021 Option Exercise$0.4319,5818,37119,581Jan 15, 2021, 04:19 PM
Skvarka JanPresident and CEOJan 13, 2021 Sale$15.045,41981,5080Jan 15, 2021, 04:19 PM
Skvarka JanPresident and CEOJan 14, 2021 Sale$15.0319,581294,2790Jan 15, 2021, 04:19 PM
Uger RobertChief Scientific OfficerJan 11, 2021 Option Exercise$9.575845,587584Jan 13, 2021, 04:12 PM
Uger RobertChief Scientific OfficerJan 11, 2021 Sale$15.205848,8790Jan 13, 2021, 04:12 PM
Petrova PenkaChief Development OfficerJan 11, 2021 Option Exercise$9.575084,860508Jan 13, 2021, 04:11 PM
Petrova PenkaChief Development OfficerJan 11, 2021 Sale$15.215087,7250Jan 13, 2021, 04:11 PM
Parsons James T.Chief Financial OfficerJan 08, 2021 Option Exercise$7.248,50561,6168,505Jan 12, 2021, 04:12 PM
Parsons James T.Chief Financial OfficerJan 08, 2021 Sale$15.798,505134,2710Jan 12, 2021, 04:12 PM
Uger RobertChief Scientific OfficerJan 08, 2021 Option Exercise$8.388,51771,3655,600Jan 12, 2021, 04:11 PM
Uger RobertChief Scientific OfficerJan 08, 2021 Sale$15.718,517133,8060Jan 12, 2021, 04:11 PM
Petrova PenkaChief Development OfficerJan 08, 2021 Option Exercise$3.332,6048,6742,604Jan 12, 2021, 04:10 PM
Petrova PenkaChief Development OfficerJan 08, 2021 Sale$15.502,60440,3650Jan 12, 2021, 04:10 PM
Petrova PenkaChief Development OfficerJan 07, 2021 Option Exercise$0.302,7088092,708Jan 11, 2021, 04:19 PM
Petrova PenkaChief Development OfficerJan 07, 2021 Sale$14.712,70839,8430Jan 11, 2021, 04:19 PM
Uger RobertChief Scientific OfficerJan 07, 2021 Option Exercise$0.303,6461,0893,646Jan 11, 2021, 04:17 PM
Uger RobertChief Scientific OfficerJan 07, 2021 Sale$14.753,64653,7820Jan 11, 2021, 04:17 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Uger RobertChief Scientific Officer07/07/20211,108
Uger RobertChief Scientific Officer07/07/202132,814
Uger RobertChief Scientific Officer04/07/20211,098
Uger RobertChief Scientific Officer04/07/202139,450
Petrova PenkaChief Development Officer04/08/20219,578
Petrova PenkaChief Development Officer04/08/202158,910
Uger RobertChief Scientific Officer03/12/20219,896
Uger RobertChief Scientific Officer03/12/202134,916
Petrova PenkaChief Development Officer03/10/20219,545
Petrova PenkaChief Development Officer03/10/202158,857
Uger RobertChief Scientific Officer03/08/20211,093
Uger RobertChief Scientific Officer03/08/202136,861
Petrova PenkaChief Development Officer02/09/20214,888
Petrova PenkaChief Development Officer02/08/20219,435
Petrova PenkaChief Development Officer02/09/20217,200
Petrova PenkaChief Development Officer02/08/202167,197
Uger RobertChief Scientific Officer02/09/20215,619
Uger RobertChief Scientific Officer02/08/202110,751
Uger RobertChief Scientific Officer02/09/20218,248
Uger RobertChief Scientific Officer02/08/202183,022
Skvarka JanPresident and CEO01/13/20212,302
Skvarka JanPresident and CEO01/14/20218,371
Skvarka JanPresident and CEO01/13/202181,508
Skvarka JanPresident and CEO01/14/2021294,279
Uger RobertChief Scientific Officer01/11/20215,587
Uger RobertChief Scientific Officer01/11/20218,879
Petrova PenkaChief Development Officer01/11/20214,860
Petrova PenkaChief Development Officer01/11/20217,725
Parsons James T.Chief Financial Officer01/08/202161,616
Parsons James T.Chief Financial Officer01/08/2021134,271
Uger RobertChief Scientific Officer01/08/202171,365
Uger RobertChief Scientific Officer01/08/2021133,806
Petrova PenkaChief Development Officer01/08/20218,674
Petrova PenkaChief Development Officer01/08/202140,365
Petrova PenkaChief Development Officer01/07/2021809
Petrova PenkaChief Development Officer01/07/202139,843
Uger RobertChief Scientific Officer01/07/20211,089
Uger RobertChief Scientific Officer01/07/202153,782
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR TRILLIUM THERAPEUTICS INC
LOADING...